Procord is an experimental cell therapy that
is being developed for the treatment of patients with a recent
spinal cord injury. Phase I clinical trials of the experimental
procedure were conducted from 2000 to 2003 in Israel and Belgium.
Since late 2003, Proneuron is sponsoring a Phase II clinical trial
at hospitals in the USA and Israel.
Recruitment to the
ProCord clinical trial is currently suspended
to make it clear that the reason for the suspension is
not the result of any clinical or safety concerns.
Clinical follow-up is being continued on those patients already
enrolled in the study